Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: patient recorded as having no known allergies to drugs attending: chief complaint: esrd major surgical or invasive procedure: renal transplant : kidney biopsy : kidney biopsy history of present illness: 32 y.o. male with esrd secondary to chronic focal sclerosing glomerulonephritis s/ failed crt past medical history: esrd on hd (m,w,f) ( glomerulonephritis) htn hypercholesterolemia * psh: avf - r radial-cephalic avf - l aneurysm resection tunneled l subclavian catheter social history: denies tobacco, etoh, drugs family history: sister who is 26 also has esrd on hd (?etiology) physical exam: vs: 98.7, 89 nsr, 164/109, 20, 97%ra gen: nad, a+ox3, heent: slera anicteric card: rrr, no m/r/g lungs: cta bilaterally abd: soft, nt, nd, +bs, well healed rlq incision extr: no c/c/e, r forearm av fistula, well healed lue av fistula neuro: cnii-xii intact pertinent results: on admission: wbc-5.8 rbc-3.88* hgb-10.5* hct-32.3* mcv-83 mch-27.1 mchc-32.5 rdw-18.2* plt ct-157 pt-12.6 ptt-30.8 inr(pt)-1.1 glucose-144* urean-74* creat-14.6*# na-140 k-5.5* cl-99 hco3-23 angap-24* alt-7 ast-7 alkphos-353* amylase-204* totbili-0.3 albumin-4.2 calcium-9.3 phos-9.3* mg-2.8* on discharge: wbc-4.7 rbc-3.03* hgb-8.3* hct-25.3* mcv-84 mch-27.3 mchc-32.7 rdw-17.5* plt ct-134* glucose-91 urean-49* creat-4.7* na-139 k-3.9 cl-107 hco3-21* angap-15 calcium-8.9 phos-4.3 mg-2.1 fk506-10.1 brief hospital course: he underwent cadaveric renal transplant into left iliac fossac on by dr. . please see operative report for details. he received standard induction immunosuppression consisting of solumedrol taper, atg, and cellcept. his solumedrol was tapered. atg was given for a total of 3 doses. cellcept was well tolerated. urine output was excellent with 200-300cc per hour. creatinine trended down to 11.2 from 15.9 by pod 2. diet was advanced without problems. was ambulatory. the incision was clean, dry and intact. he experienced hypertension postop and labetolol was restarted and increased with improvement of bp. creatinine trended down to nadir of 2.9 on pod 6 and then it began to rise again. blood pressure was difficult to control and nifedipine and minoxidil were added back. the patient underwent a kidney biopsy on pod 7 which showed: acute humoral rejection, banff type ii, (capillaritis/thrombotic microangiopathy pattern) he was started on plasmapheresis and ivig, and also received an additional 4 doses of atg 100 mg each. ivig for the initial dosing was 90gms at completion of course.he also underwent a few treatments of hemodialysis, in general for volume as his urine output decreased to 300cc/day at the lowest point. biopsy was repeated on as well as repeat of antibody screen. this was reported as improved but not resolved. pheresis was restarted, he received a dose of rituximab on following the pheresis. in addition the ivig was started with an additional 40 gms. patient will complete pheresis/ivig course as an outpatient with an additional 2 treatments scheduled. creatinine fluctuates from 4.2-5.0 urine output increased again to 1.5-2l daily. he has not received additional hemodialysis, last hd . medications on admission: lisinopril 60', minoxidil 10', labetalol 800', nifedipine 60', sensipar 30', phoslo tt c meals discharge medications: 1. trimethoprim-sulfamethoxazole 80-400 mg tablet sig: one (1) tablet po daily (daily). 2. nystatin 100,000 unit/ml suspension sig: five (5) ml po qid (4 times a day). 3. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2 times a day). disp:*60 capsule(s)* refills:*2* 4. valganciclovir 450 mg tablet sig: one (1) tablet po q48h (every 48 hours). 5. senna 8.6 mg tablet sig: one (1) tablet po bid (2 times a day). disp:*60 tablet(s)* refills:*2* 6. labetalol 200 mg tablet sig: five (5) tablet po bid (2 times a day). 7. pantoprazole 40 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po q12h (every 12 hours). 8. nifedipine 60 mg tablet sustained release sig: one (1) tablet sustained release po bid (2 times a day). 9. prednisone 5 mg tablet sig: 3.5 tablets po daily (daily). 10. mycophenolate mofetil 500 mg tablet sig: three (3) tablet po bid (2 times a day). 11. tacrolimus 5 mg capsule sig: two (2) capsule po twice a day. 12. tylenol 325 mg tablet sig: 1-2 tablets po every 6-8 hours as needed for pain. discharge disposition: home discharge diagnosis: esrd s/p kidney transplant htn humoral rejection discharge condition: good discharge instructions: please call transplant office if fevers, chills, nausea, vomiting, inability to take medications, incision redness/bleeding/drainage, decreased urine output, weight gain of 3 pounds in a day. call if you do not have any of your medication right away. labs every monday and thursday for cbc, chem 7, calcium phos, ast, t.bili, albumin, urinalysis and trough prograf level. fax results to come for outpatient pheresis on monday and weds followup instructions: , md phone: date/time: 10:10 pheresis,bed eight pheresis rooms date/time: 8:00 pheresis,bed three pheresis rooms date/time: 8:15 procedure: hemodialysis closed [percutaneous] [needle] biopsy of kidney closed [percutaneous] [needle] biopsy of kidney other kidney transplantation therapeutic plasmapheresis transfusion of packed cells transfusion of other serum injection or infusion of immunoglobulin injection or infusion of biological response modifier [brm] as an antineoplastic agent other operations on lacrimal gland transplant from cadaver diagnoses: end stage renal disease pure hypercholesterolemia long-term (current) use of steroids acute kidney failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease long-term (current) use of other medications surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation complications of transplanted kidney neutropenia, unspecified chronic glomerulonephritis with lesion of membranous glomerulonephritis 

Answer: The patient is high likely exposed to